ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

NO

NEXT Oncology at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

NEXT Oncology takes part in 7 sessions at ESMO 2026 in Madrid. Its research centres on early testing of targeted drugs and antibody-drug conjugates in advanced cancers. The studies include drugs directed at KRAS-altered tumors and DLL3-expressing tumors, as well as combinations for pancreatic and lung cancers.

OrganizationESMO 2026 Attendance
NO
NEXT Oncology
San Antonio, TX
Cancer centre & hospital
Early-phase cancer drug trial network with clinical research sites in the United States and Spain.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Chair
Sat Oct 24
14:45–16:15
Proffered paper: Developmental therapeutics
with MD Anderson Cancer Center
Talk
Tue Oct 27
11:20–11:40
Developmental therapeutics
Scientific Congress Highlights 1

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at NEXT Oncology

Tell us what you sell and we’ll find the people at NEXT Oncology most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction